Effect of Batroxobin on Thromboxane Level in Canine with Myocardial Ischemia/reperfusion Injury
郑直,张勇刚,符民桂,夏春芳,唐朝枢,刘乃奎
DOI: https://doi.org/10.3321/j.issn:1000-4718.2001.01.008
2001-01-01
Abstract:AIM:To investigate the effect of batroxobin on thromboxaneA2(TXA2)level in canine heart ischemia/reperfusion (I/R) injury and the cardioprotective mechanism of batroxobin against I/R injury. METHODS: Canine heart ischemia was induced by ligation of the left anterior descending coronary artery for 30 min followed by 90 min reperfusion.Batroxobin was intravenously administered before heart ischemia and 15 min before reperfusion.The level of plasma thromboxane (TXA2) ,creatine phosphokinase (CK), lactic dehydrogenase (LDH ) and the concentration of myocardial TXA2 were measured. The pathological changes in I/R myocardium were observed. RESULTS: In I/R group, TXA2 levels of both plasma and myocardium increased significantly,and myocardium was injured obviously. Myocyte cells of central zone of I/R heart showed intracellular edema, swollen and damaged mitochondria, and fragmentation of cristae and concentrated nucleus. Plasma CK and LDH level was also elevated. Both ways of batroxobin administration reduced TXA2 level apparently and plasma CK、LDH were also reduced significantly. LVEDP lowered while +dp/dt max elevated greatly,the mortality of I/R canine reduced obviously. CONCLUSION: Batroxobin decreased TXA2 levels of both plasma and myocardium significantly, and could afford protection from I/R injury.
What problem does this paper attempt to address?